Adjuvant sorafenib in hepatocellular carcinoma: A cautionary comment of STORM trial

DOI: 10.4254/wjh.v8.i23.957

Keywords: Adjuvant, Hepatocellular carcinoma, Tumor recurrence, Sorafenib

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text